This respected group of retina specialists will discuss biosimilar anti-VEGF therapies. Learn how they compare with their reference products, the process by which they gain FDA approval, their risks and benefits, and the policies that may influence incorporation into clinical practice.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Upon completion of this activity, the participant should be able to:
This educational activity is provided by Evolve Medical Education LLC (Evolve).
Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Sumit Sharma, MD
Assistant Professor, Ophthalmology
Cleveland Clinic
Lerner College of Medicine
Case Western Reserve University Staff
in Vitreoretinal Surgery and Uveitis
Cleveland Clinic Cole Eye Institute
Cleveland, OH
Sophie J. Bakri, MD
Professor and Chair
Department of Ophthalmology
Mayo Clinic
Rochester, MN
Ankoor R. Shah, MD
Retina Consultants of Texas
Houston, TX
Ashish Sharma, MD
Lotus Eye Hospital and Institute
Coimbatore, TN, India
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Sumit Sharma, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Bausch + Lomb, Clearside, EyePoint Pharmaceuticals, Genentech, Regeneron, and RegenxBio. Grant/Research Support: Genentech, Gilead Sciences, Ionis, and Santen.
Sophie J. Bakri, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Adverum, Abbvie, Alimera, Apellis, Carl Zeiss Meditec, Eyepoint Pharmaceuticals, Genentech, ilumen, Kala Pharmaceuticals, Novartis, Pixium, Regenxbio, Revana, Roche, and VoxelCloud.
Ankoor R. Shah, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb and RegenxBio.
Ashish Sharma, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Bayer, Biogen, Intas, Lupin, Novartis, and Reliance. Speaker’s Bureau: Allergan, Bayer, Biogen, Intas, Lupin, Novartis, and Reliance.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals, Inc.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
